Tag Archives: National Institutes of Health

XDR-TB patient in U.S. highlights global reach of infectious disease

By on .

While health officials seek fellow passengers, researchers seek a vaccine If an argument is needed against prioritizing United States medical research dollars simply on the basis of disease burden in the U.S., global health advocates in Washington, DC didn’t have to look any farther this week than the National Institutes of Health campus in Maryland. […]

Brief: Flat funding of biomedical research costs lives, slows progress, hurts economy, and diminishes America’s leadership

By on .

A decade-long trend of diminished investment in medical research, exacerbated by budget-standoff driven “sequester” cuts are showing immediate and long term impacts: in stymieing promising studies, and in thwarting the development of the next generation of scientists, according to a brief from amfAR, the Foundation for AIDS Research and TAG, Treatment Action Group. The brief […]

Congress finalizes FY 2013 budget with PEPFAR cut, Global Fund boost

By on .

The President’s Emergency Plan for AIDS Relief  took a hit while the Global Fund to Fight AIDS, Tuberculosis and Malaria got a boost last week when the House and Senate passed a Continuing Resolution bill to avoid a government shutdown and continue funding the government through Oct. 1, the end of fiscal year 2013. The […]

New ranking member of Senate Appropriations HHS subcommittee gets mixed reviews

By on .

“Given the vast amount of progress made over the last century and the great potential current research holds, now is not the time to waiver on America’s commitment to advancing disease cures and treatments.” These are welcome words from the senator who now holds a leadership position on the subcommittee that oversees funding for the […]

The human toll, setbacks to science, and “the only thing worse than sequestration . . .”

By on .

As looming spending cuts preoccupy the press, here’s a glimpse of impacts and how members of the Senate Foreign Relations Committee are taking it, in an all-sequestration edition of What We’re Reading . . . US faces fresh financial shock: The recent pause at the edge of the fiscal cliff may have seemed to signal […]

NIH-funded TB drug trial is latest effort to fill treatment pipeline

By on .

A 14-day trial enrolling 75 Cape Town South Africa patients, to see if a new investigational drug lowers tuberculosis bacteria counts represents the latest hope for filling the need for treatment options for the disease, the National Institutes of Health announced this week. The NIH is sponsoring the trial led by Case Western Reserve researchers […]

In lives, health, medical progress, and lost ground — reports tally cost of Budget Control Act

By on .

When legislators went home last week, they left a Continuing Resolution to keep the country running and with it, they left standing the numbers the U.S. Office of Management and Budget cited to estimate the impact of the Budget Control Act’s January 2, 2013 automatic sweeping funding cuts on  government programs, including those responsible for […]

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]